Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Irhythm Technologies Inc (NQ: IRTC )

70.28 -2.80 (-3.83%)
Streaming Delayed Price Updated: 3:52 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 278,810
Open 72.73
Bid (Size) 70.21 (2)
Ask (Size) 70.35 (2)
Prev. Close 73.08
Today's Range 69.69 - 73.59
52wk Range 60.88 - 124.11
Shares Outstanding 29,403,360
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
From iRhythm
Via GlobeNewswire
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
From iRhythm
Via GlobeNewswire

Performance

YTD
-30.65%
-30.65%
1 Month
+0.50%
+0.50%
3 Month
-33.30%
-33.30%
6 Month
-35.81%
-35.81%
1 Year
-21.36%
-21.36%

More News

Read More
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
From iRhythm
Via GlobeNewswire
Expert Ratings For iRhythm Technologies
Via Benzinga
iRhythm Technologies Announces Results of GUARD-AF Trial
From iRhythm
Via GlobeNewswire
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Via Benzinga
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
From iRhythm
Via GlobeNewswire
4 Analysts Assess iRhythm Technologies: What You Need To Know
Via Benzinga
The Analyst Verdict: iRhythm Technologies In The Eyes Of 5 Experts
Via Benzinga
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
From iRhythm
Via GlobeNewswire
IRTC Stock Earnings: iRhythm Technologies Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
iRhythm Technologies Announces Chief Financial Officer Transition
From iRhythm
Via GlobeNewswire
iRhythm Technologies Announces Second Quarter 2024 Financial Results
From iRhythm
Via GlobeNewswire
7 Leading MedTech Stocks for Next-Gen Health Solutions
Via InvestorPlace
7 Robotics Stocks That Could Grow Your Wealth
Via InvestorPlace
3 Healthcare Stocks to Buy Now: Q3 Edition
Via InvestorPlace
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
From iRhythm
Via GlobeNewswire
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
Via Benzinga
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
From iRhythm
Via GlobeNewswire
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Via Benzinga
J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday
Via Benzinga
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
From iRhythm
Via GlobeNewswire
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
From iRhythm
Via GlobeNewswire
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.